H. Döhner, E. Estey, S. Amadori, F. Appelbaum, T. Büchner et al., Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-74, 2010.
DOI : 10.1182/blood-2009-07-235358

C. Baldus, K. Mrózek, G. Marcucci, and C. Bloomfield, Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review, British Journal of Haematology, vol.61, issue.5, pp.387-400, 2007.
DOI : 10.1038/sj.bmt.1705169

D. Grimwade, H. Walker, F. Oliver, K. Wheatley, C. Harrison et al., The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties, Blood, vol.92, pp.2322-2355, 1998.

D. Breems, W. Van-putten, D. Greef, G. Van-zelderen-bhola, S. Gerssen-schoorl et al., Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype, Journal of Clinical Oncology, vol.26, issue.29, pp.4791-4798, 2008.
DOI : 10.1200/JCO.2008.16.0259

S. Iqbal, D. Grimwade, A. Chase, A. Goldstone, A. Burnett et al., Identification of PML/RAR?? rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients, Leukemia, vol.14, issue.5, pp.950-953, 2000.
DOI : 10.1038/sj.leu.2401688

D. Grimwade, A. Biondi, M. Mozziconacci, A. Hagemeijer, R. Berger et al., Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action " Molecular Cytogenetic Diagnosis in Haematological Malignancies, Blood, vol.96, pp.1297-308, 2000.

M. Mitterbauer, R. Kusec, I. Schwarzinger, O. Haas, K. Lechner et al., Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML, Annals of Hematology, vol.76, issue.3-4, pp.139-182, 1998.
DOI : 10.1007/s002770050378

D. Rowe, S. Cotterill, F. Ross, D. Bunyan, S. Vickers et al., Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia, Br J Haematol, vol.111, pp.1051-1057, 2000.

K. Mrózek, T. Prior, C. Edwards, G. Marcucci, A. Carroll et al., Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study, Journal of Clinical Oncology, vol.19, issue.9, pp.2482-92, 2001.
DOI : 10.1200/JCO.2001.19.9.2482

R. Verhaak, B. Wouters, C. Erpelinck, S. Abbas, H. Beverloo et al., Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling, Haematologica, vol.94, issue.1, pp.131-135, 2009.
DOI : 10.3324/haematol.13299

P. Valk, R. Verhaak, M. Beijen, C. Erpelinck, B. Van-waalwijk-van-doorn-khosrovani et al., Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia, New England Journal of Medicine, vol.350, issue.16, pp.1617-1645, 2004.
DOI : 10.1056/NEJMoa040465

L. Bullinger, K. Döhner, E. Bair, S. Fröhling, R. Schlenk et al., Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia, New England Journal of Medicine, vol.350, issue.16, pp.1605-1621, 2004.
DOI : 10.1056/NEJMoa031046

T. Haferlach, A. Kohlmann, L. Wieczorek, G. Basso, G. Kronnie et al., Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group, Journal of Clinical Oncology, vol.28, issue.15, pp.2529-2566, 2010.
DOI : 10.1200/JCO.2009.23.4732

T. Haferlach, A. Kohlmann, S. Schnittger, M. Dugas, W. Hiddemann et al., Global approach to the diagnosis of leukemia using gene expression profiling, Blood, vol.106, issue.4, pp.1189-98, 2005.
DOI : 10.1182/blood-2004-12-4938

C. Schoch, A. Kohlmann, S. Schnittger, B. Brors, M. Dugas et al., Acute myeloid leukemias with de la Blétière et al. BMC6 reciprocal rearrangements can be distinguished by specific gene expression profiles, Medical Genomics Proc Natl Acad Sci, vol.5, issue.99, pp.10008-10021, 2002.

A. Kohlmann, C. Schoch, S. Schnittger, M. Dugas, W. Hiddemann et al., Molecular characterization of acute leukemias by use of microarray technology, Genes, Chromosomes and Cancer, vol.99, issue.4, pp.396-405, 2003.
DOI : 10.1002/gcc.10225

N. Gutiérrez, R. López-pérez, J. Hernández, I. Isidro, B. González et al., Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia, Leukemia, vol.19, issue.3, pp.402-411, 2005.
DOI : 10.1038/sj.leu.2403625

M. Ross, R. Mahfouz, M. Onciu, H. Liu, X. Zhou et al., Gene expression profiling of pediatric acute myelogenous leukemia, Blood, vol.104, issue.12, pp.3679-87, 2004.
DOI : 10.1182/blood-2004-03-1154

J. Gabert, E. Beillard, V. Van-der-velden, W. Bi, D. Grimwade et al., Standardization and quality control studies of ???real-time??? quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia ??? A Europe Against Cancer Program, Leukemia, vol.17, issue.12, pp.2318-57, 2003.
DOI : 10.1038/sj.leu.2403135

N. Boissel, A. Renneville, V. Biggio, P. N. Thomas, X. Cayuela et al., Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype, Blood, vol.106, issue.10, pp.3618-3638, 2005.
DOI : 10.1182/blood-2005-05-2174

M. Nakao, S. Yokota, T. Iwai, H. Kaneko, S. Horiike et al., Internal tandem duplication of the flt3 gene found in acute myeloid leukemia, Leukemia, vol.10, pp.1911-1919, 1996.

F. Abu-duhier, A. Goodeve, G. Wilson, R. Care, I. Peake et al., Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia, British Journal of Haematology, vol.79, issue.4, pp.983-991, 2001.
DOI : 10.1038/sj.leu.2400812

T. Pabst, B. Mueller, P. Zhang, H. Radomska, S. Narravula et al., Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia, Nature Genetics, vol.27, issue.3, pp.263-70, 2001.
DOI : 10.1038/85820

E. Falkenauer, E. Falkenauer, and . Chichester, The grouping genetic algorithm In Genetic Algorithms and Grouping Problems.. First edition, pp.81-110, 1998.

D. De-ridder, C. Van-der-linden, T. Schonewille, W. Dik, M. Reinders et al., Purity for clarity: the need for purification of tumor cells in DNA microarray studies, Leukemia, vol.114, pp.618-645, 2005.
DOI : 10.1073/pnas.2536479100

W. Lemon, J. Palatini, R. Krahe, and F. Wright, Theoretical and experimental comparisons of gene expression indexes for oligonucleotide arrays, Bioinformatics, vol.18, issue.11, pp.1470-1476, 2002.
DOI : 10.1093/bioinformatics/18.11.1470

R. Irizarry, B. Bolstad, C. F. Cope, L. Hobbs, B. Speed et al., Summaries of Affymetrix GeneChip probe level data, Nucleic Acids Research, vol.31, issue.4, pp.31-46, 2003.
DOI : 10.1093/nar/gng015

C. Mullighan, A. Kennedy, X. Zhou, I. Radtke, L. Phillips et al., Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias, Leukemia, vol.17, issue.9, pp.2000-2009, 2007.
DOI : 10.1038/nrc1885

R. Verhaak, C. Goudswaard, W. Van-putten, M. Bijl, M. Sanders et al., Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance, Blood, vol.106, issue.12, pp.3747-54, 2005.
DOI : 10.1182/blood-2005-05-2168

M. Alcalay, E. Tiacci, R. Bergomas, B. Bigerna, E. Venturini et al., Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance, Blood, vol.106, issue.3, pp.899-902, 2005.
DOI : 10.1182/blood-2005-02-0560

A. Kohlmann, L. Bullinger, C. Thiede, M. Schaich, S. Schnittger et al., Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways, Leukemia, vol.36, issue.6, pp.1216-1236, 2010.
DOI : 10.1038/ng.295

E. Van-beers, L. De-best, M. Van-vliet, J. Brand, P. Burgmer et al., A validated diagnostic microarray for newly diagnosed adult AML patients, Oral Communication at European Hematology Association annual meeting, 2011.

A. Kohlmann, C. Schoch, M. Dugas, S. Rauhut, F. Weninger et al., Pattern robustness of diagnostic gene expression signatures in leukemia, Genes, Chromosomes and Cancer, vol.1, issue.3, pp.299-307, 2005.
DOI : 10.1002/gcc.20126

L. Opitz, G. Salinas-riester, M. Grade, K. Jung, J. P. Emons et al., Impact of RNA degradation on gene expression profiling, BMC Medical Genomics, vol.88, issue.4, p.36, 2010.
DOI : 10.1038/labinvest.2008.11